Immunotech Laboratories, Inc. Stock
Stocks
IMMB
US45254F2039
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
21:02:22 19/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.000200 USD | 0.00% |
|
0.00% | +100.00% |
| Market Cap | 6.06M 5.42M 5M 4.53M 8.47M 577M 8.6M 59.7M 23.82M 302M 22.73M 22.24M 956M | P/E 2008 * |
-
| P/E 2009 | -310x |
|---|---|---|---|---|---|
| Enterprise Value | 7.25M 6.49M 5.99M 5.42M 10.13M 690M 10.3M 71.44M 28.5M 361M 27.19M 26.62M 1.14B | EV / Sales 2008 * |
-
| EV / Sales 2009 | - |
| Free-Float |
99.34% | Yield 2008 * |
-
| Yield 2009 | - |
| Current year | +100.00% |
| 1 month | 0 |  | 0 |
| Current year | 0 | | 0 |
| 1 year | 0 | | 0 |
| 3 years | 0 | | 0 |
| 5 years | 0 | | 0.01 |
| 10 years | 0 | | 0.09 |
| Manager | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
PSD | President | 59 | 21/12/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Harry Zhabilov
CHM | Chairman | 59 | 01/07/2014 |
| Director/Board Member | 61 | 04/02/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | 0.00% | +100.00% | 0.00% | 115K | |
| +0.34% | +1.12% | +34.75% | +61.06% | 64.14B | |
| +0.98% | +2.68% | +12.25% | +82.98% | 55.53B | |
| +1.75% | +2.01% | +13.30% | +103.69% | 53.03B | |
| -1.43% | -1.17% | +26.27% | +52.86% | 45.99B | |
| -0.48% | -2.80% | +18.01% | +117.99% | 42.45B | |
| +0.82% | +1.37% | +227.94% | +922.41% | 40.45B | |
| -0.26% | -2.57% | +12.55% | +45.18% | 32.25B | |
| -2.07% | +42.73% | +103.77% | +88.74% | 34.47B | |
| -2.49% | -4.19% | +19.96% | -13.11% | 24.23B | |
| Average | -0.30% | +3.86% | +56.88% | +146.18% | 39.25B | |
| Weighted average by Cap. | -0.07% | +3.59% | +49.10% | +160.42% |
| * | 1 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
4
- Stock Market
- Stocks
- IMMB Stock
Select your edition
All financial news and data tailored to specific country editions
